Literature DB >> 26744098

Aberrant levels of natural IgM antibodies in osteoarthritis and rheumatoid arthritis patients in comparison to healthy controls.

Tue G Nguyen1, Kelly J McKelvey2, Lyn M March3, David J Hunter3, Meilang Xue4, Christopher J Jackson4, Jonathan M Morris5.   

Abstract

Natural IgM antibodies (nIgM) are polyreactive autoantibodies that have diverse roles in regulating autoimmunity, systemic inflammation and removal of oxidized low-density lipoproteins (oxLDL). We hypothesized that aberrant states of nIgM may exist in persons with osteoarthritis (OA) and rheumatoid arthritis (RA). Herein, we characterized and compared the levels of nIgM specific for phosphorylcholine (anti-PC), double-stranded DNA (anti-dsDNA), and galactosyl (anti-Gal) in persons with OA, RA and healthy controls (HC). Levels of anti-PC nIgM in OA patients were significantly lower than both HC and RA patients in an age-adjusted analysis (P<0.05). In contrast, anti-Gal nIgM levels were significantly higher in RA patients than OA patients (P<0.05) and markedly increased in comparison to HC. Anti-PC nIgM significantly correlated with anti-dsDNA and anti-Gal nIgM levels in HC and RA (P<0.05) but not in OA patients. Elevated CRP levels were associated with RA conditions and old ages in general. There was no significant correlation between anti-PC nIgM and CRP or oxLDL levels. Our study highlights for the first time the evidence of aberrant state of nIgM in human OA compared to healthy individuals that implicates a deficiency in immune responses to oxLDL which may contribute to the metabolic syndromes in the development of OA.
Copyright © 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-dsDNA; Anti-galactosyl; Anti-phosphorylcholine; Natural IgM; Osteoarthritis; Rheumatoid arthritis

Mesh:

Substances:

Year:  2015        PMID: 26744098     DOI: 10.1016/j.imlet.2015.12.009

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Prenatal toxoplasmosis antibody and childhood autism.

Authors:  Marisa N Spann; Andre Sourander; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Alan S Brown
Journal:  Autism Res       Date:  2016-11-22       Impact factor: 5.216

2.  The association between oxidized low-density lipoprotein antibodies and hematological diseases.

Authors:  Hao Li; Da-Qing Li; Xiang-Xin Li; Lu-Qun Wang
Journal:  Lipids Health Dis       Date:  2016-11-08       Impact factor: 3.876

3.  IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases.

Authors:  Divya Thiagarajan; Nina Oparina; Susanna Lundström; Roman Zubarev; Jitong Sun; Marta Alarcon-Riquelme; Johan Frostegård
Journal:  Sci Rep       Date:  2020-07-03       Impact factor: 4.379

4.  Potential natural immunization against atherosclerosis in hibernating bears.

Authors:  Shailesh Kumar Samal; Ole Fröbert; Jonas Kindberg; Peter Stenvinkel; Johan Frostegård
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

5.  Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects.

Authors:  Johan Frostegård; M Magnusson; Amra Jujić; J Korduner; H Holm; G Engström; E Bachus; P Bhattacharya; P M Nilsson
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

6.  Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions.

Authors:  Shailesh Kumar Samal; Pritam Kumar Panda; Max Vikström; Karin Leander; Ulf de Faire; Rajeev Ahuja; Johan Frostegård
Journal:  Front Cardiovasc Med       Date:  2022-04-11

7.  Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality.

Authors:  S K Samal; A R Qureshi; M Rahman; P Stenvinkel; J Frostegård
Journal:  Clin Exp Immunol       Date:  2020-05-18       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.